Austar Lifesciences' low P/S ratio may be a buying opportuni...

Austar Lifesciences' low P/S ratio may be a buying opportunity, but its poor financial performance and declining revenue are concerning. Despite higher medium-term revenue growth rates than the industry average, the continued decline in stock price and P/S ratio indicates potential risks.